| Product Code: ETC9963464 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Coronary Artery Disease Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Coronary Artery Disease Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Coronary Artery Disease Market - Industry Life Cycle |
3.4 United States (US) Coronary Artery Disease Market - Porter's Five Forces |
3.5 United States (US) Coronary Artery Disease Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 United States (US) Coronary Artery Disease Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 United States (US) Coronary Artery Disease Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.8 United States (US) Coronary Artery Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Coronary Artery Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of risk factors such as obesity, diabetes, and high cholesterol leading to a higher incidence of coronary artery disease. |
4.2.2 Technological advancements in diagnostic tools and treatment options improving patient outcomes and increasing demand for services. |
4.2.3 Growing aging population in the United States leading to a higher number of individuals at risk of developing coronary artery disease. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and approval processes for new drugs and medical devices limiting innovation and market entry. |
4.3.2 High costs associated with coronary artery disease treatments and procedures leading to financial burden for patients and healthcare systems. |
4.3.3 Increasing competition among healthcare providers and insurance companies leading to pricing pressures and reduced profitability. |
5 United States (US) Coronary Artery Disease Market Trends |
6 United States (US) Coronary Artery Disease Market, By Types |
6.1 United States (US) Coronary Artery Disease Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Coronary Artery Disease Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 United States (US) Coronary Artery Disease Market Revenues & Volume, By Electrocardiogram, 2021- 2031F |
6.1.4 United States (US) Coronary Artery Disease Market Revenues & Volume, By Echocardiogram, 2021- 2031F |
6.1.5 United States (US) Coronary Artery Disease Market Revenues & Volume, By Stress Test, 2021- 2031F |
6.1.6 United States (US) Coronary Artery Disease Market Revenues & Volume, By Cardiac catheterization, 2021- 2031F |
6.1.7 United States (US) Coronary Artery Disease Market Revenues & Volume, By Heart CT Scan, 2021- 2031F |
6.1.8 United States (US) Coronary Artery Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Coronary Artery Disease Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Coronary Artery Disease Market Revenues & Volume, By Medication, 2021- 2031F |
6.2.3 United States (US) Coronary Artery Disease Market Revenues & Volume, By Surgery, 2021- 2031F |
6.2.4 United States (US) Coronary Artery Disease Market Revenues & Volume, By Additional Therapy, 2021- 2031F |
6.2.5 United States (US) Coronary Artery Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) Coronary Artery Disease Market, By End Users |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Coronary Artery Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 United States (US) Coronary Artery Disease Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.3.4 United States (US) Coronary Artery Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) Coronary Artery Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Coronary Artery Disease Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 United States (US) Coronary Artery Disease Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.4.4 United States (US) Coronary Artery Disease Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.4.5 United States (US) Coronary Artery Disease Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Coronary Artery Disease Market Import-Export Trade Statistics |
7.1 United States (US) Coronary Artery Disease Market Export to Major Countries |
7.2 United States (US) Coronary Artery Disease Market Imports from Major Countries |
8 United States (US) Coronary Artery Disease Market Key Performance Indicators |
8.1 Average hospital length of stay for coronary artery disease patients. |
8.2 Percentage of patients receiving guideline-recommended treatments. |
8.3 Number of new technologies or treatment modalities introduced to the market. |
8.4 Patient satisfaction scores with coronary artery disease care. |
8.5 Rate of readmission for coronary artery disease patients within 30 days. |
9 United States (US) Coronary Artery Disease Market - Opportunity Assessment |
9.1 United States (US) Coronary Artery Disease Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 United States (US) Coronary Artery Disease Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 United States (US) Coronary Artery Disease Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.4 United States (US) Coronary Artery Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Coronary Artery Disease Market - Competitive Landscape |
10.1 United States (US) Coronary Artery Disease Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Coronary Artery Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here